￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What are the effects of EIKANCE (0.01% atropine sulfate eye drops)

2026-02-01 22:25:32

Check Details
The efficacy and function of EIKANCE (0.01% atropine sulfate eye drops)

2026-02-01 22:25:32

Check Details
What is EIKANCE (0.01% Atropine Sulfate Eye Drops) used to treat?

2026-02-01 22:25:32

Check Details
Are there any precautions to take while using EIKANCE (0.01% Atropine Sulfate Eye Drops)?

2026-02-01 22:25:32

Check Details
Precautions that patients taking Mobotinib must know

2026-02-01 22:25:32

Check Details
Did Jisandai (Bingtonsha) relapse after three months of treatment? Coping strategies and precautions

2026-02-01 22:25:32

Check Details
Jisandai (Bingtonsha): an efficient choice for hepatitis C treatment?

2026-02-01 22:25:32

Check Details
What effect does Jisandai (Bingtonsha) have on renal function in treating hepatitis C?

2026-02-01 22:25:32

Check Details
How long is the standard course of treatment for hepatitis C with Jisandai (Bingtonsha)?

2026-02-01 22:25:32

Check Details
Is there any risk of hepatotoxicity with Jisandai (Bingtonsha) in treating hepatitis C?

2026-02-01 22:25:32

Check Details
Possible adverse reactions and precautions of Jisandai (Bingtonsha) in the treatment of hepatitis C

2026-02-01 22:25:32

Check Details
Comprehensive comparative analysis of domestic and imported drugs of Jisandai (Bingtonsha)

2026-02-01 22:25:32

Check Details
Category
相关知识